223 related articles for article (PubMed ID: 17593664)
1. NKT cells and autoimmune diseases: unraveling the complexity.
Miyake S; Yamamura T
Curr Top Microbiol Immunol; 2007; 314():251-67. PubMed ID: 17593664
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic potential of glycolipid ligands for natural killer (NK) T cells in the suppression of autoimmune diseases.
Miyake S; Yamamura T
Curr Drug Targets Immune Endocr Metabol Disord; 2005 Sep; 5(3):315-22. PubMed ID: 16178791
[TBL] [Abstract][Full Text] [Related]
3. Immunoregulation of autoimmunity by natural killer T cells.
Linsen L; Somers V; Stinissen P
Hum Immunol; 2005 Dec; 66(12):1193-202. PubMed ID: 16690406
[TBL] [Abstract][Full Text] [Related]
4. Natural killer T cells and autoimmune disease.
Wu L; Van Kaer L
Curr Mol Med; 2009 Feb; 9(1):4-14. PubMed ID: 19199937
[TBL] [Abstract][Full Text] [Related]
5. Potential of targeting natural killer T cells for the treatment of autoimmune diseases.
Miyake S; Chiba A; Yamamura T
Mod Rheumatol; 2004 Sep; 14(4):279-84. PubMed ID: 24387645
[TBL] [Abstract][Full Text] [Related]
6. NKT cells: potential targets for autoimmune disease therapy?
Hammond KJ; Godfrey DI
Tissue Antigens; 2002 May; 59(5):353-63. PubMed ID: 12144618
[TBL] [Abstract][Full Text] [Related]
7. Role of invariant natural killer T (iNKT) cells in systemic lupus erythematosus.
Godó M; Sessler T; Hamar P
Curr Med Chem; 2008; 15(18):1778-87. PubMed ID: 18691038
[TBL] [Abstract][Full Text] [Related]
8. [iNKT cells, a friend or a foe for autoimmune disease and allergy?].
Miyake S
Nihon Rinsho Meneki Gakkai Kaishi; 2006 Feb; 29(1):27-36. PubMed ID: 16505600
[TBL] [Abstract][Full Text] [Related]
9. Natural killer T cells: natural or unnatural regulators of autoimmunity?
Hammond KJ; Kronenberg M
Curr Opin Immunol; 2003 Dec; 15(6):683-9. PubMed ID: 14630203
[TBL] [Abstract][Full Text] [Related]
10. Immune regulation by invariant NKT cells in autoimmunity.
Ronchi F; Falcone M
Front Biosci; 2008 May; 13():4827-37. PubMed ID: 18508548
[TBL] [Abstract][Full Text] [Related]
11. Natural killer T cell activation protects mice against experimental autoimmune encephalomyelitis.
Singh AK; Wilson MT; Hong S; Olivares-Villagómez D; Du C; Stanic AK; Joyce S; Sriram S; Koezuka Y; Van Kaer L
J Exp Med; 2001 Dec; 194(12):1801-11. PubMed ID: 11748281
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic potential of CD1d-restricted invariant natural killer T cell-based treatment for autoimmune diseases.
Miyake S; Yamamura T
Int Rev Immunol; 2007; 26(1-2):73-94. PubMed ID: 17454265
[TBL] [Abstract][Full Text] [Related]
13. Invariant NKT cells regulate experimental autoimmune encephalomyelitis and infiltrate the central nervous system in a CD1d-independent manner.
Mars LT; Gautron AS; Novak J; Beaudoin L; Diana J; Liblau RS; Lehuen A
J Immunol; 2008 Aug; 181(4):2321-9. PubMed ID: 18684921
[TBL] [Abstract][Full Text] [Related]
14. Prevention of autoimmunity by targeting a distinct, noninvariant CD1d-reactive T cell population reactive to sulfatide.
Jahng A; Maricic I; Aguilera C; Cardell S; Halder RC; Kumar V
J Exp Med; 2004 Apr; 199(7):947-57. PubMed ID: 15051763
[TBL] [Abstract][Full Text] [Related]
15. The natural killer T lymphocyte: a player in the complex regulation of autoimmune diabetes in non-obese diabetic mice.
Cardell SL
Clin Exp Immunol; 2006 Feb; 143(2):194-202. PubMed ID: 16412042
[TBL] [Abstract][Full Text] [Related]
16. Regulation of autoimmune disease by natural killer T cells.
Sharif S; Arreaza GA; Zucker P; Mi QS; Delovitch TL
J Mol Med (Berl); 2002 May; 80(5):290-300. PubMed ID: 12021841
[TBL] [Abstract][Full Text] [Related]
17. Interdependency of MHC class II/self-peptide and CD1d/self-glycolipid presentation by TNF-matured dendritic cells for protection from autoimmunity.
Wiethe C; Schiemann M; Busch D; Haeberle L; Kopf M; Schuler G; Lutz MB
J Immunol; 2007 Apr; 178(8):4908-16. PubMed ID: 17404272
[TBL] [Abstract][Full Text] [Related]
18. Up-regulation of CD1d expression restores the immunoregulatory function of NKT cells and prevents autoimmune diabetes in nonobese diabetic mice.
Falcone M; Facciotti F; Ghidoli N; Monti P; Olivieri S; Zaccagnino L; Bonifacio E; Casorati G; Sanvito F; Sarvetnick N
J Immunol; 2004 May; 172(10):5908-16. PubMed ID: 15128771
[TBL] [Abstract][Full Text] [Related]
19. Testing the NKT cell hypothesis of human IDDM pathogenesis.
Lee PT; Putnam A; Benlagha K; Teyton L; Gottlieb PA; Bendelac A
J Clin Invest; 2002 Sep; 110(6):793-800. PubMed ID: 12235110
[TBL] [Abstract][Full Text] [Related]
20. The role of NK cells in autoimmune disease.
Baxter AG; Smyth MJ
Autoimmunity; 2002 Feb; 35(1):1-14. PubMed ID: 11908701
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
